Vanguard Personalized Indexing Management LLC Purchases 2,679 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Vanguard Personalized Indexing Management LLC lifted its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 38.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 9,668 shares of the company’s stock after purchasing an additional 2,679 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Acadia Healthcare were worth $752,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Headlands Technologies LLC bought a new position in shares of Acadia Healthcare in the third quarter worth $25,000. GAMMA Investing LLC bought a new position in shares of Acadia Healthcare in the fourth quarter worth $26,000. Fifth Third Bancorp increased its stake in Acadia Healthcare by 25.5% in the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after acquiring an additional 136 shares during the last quarter. DekaBank Deutsche Girozentrale purchased a new stake in Acadia Healthcare during the third quarter valued at about $96,000. Finally, Oak Thistle LLC purchased a new stake in Acadia Healthcare during the fourth quarter valued at about $235,000.

Insider Buying and Selling at Acadia Healthcare

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the sale, the director now directly owns 46,074 shares of the company’s stock, valued at approximately $3,934,258.86. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 2.00% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have weighed in on ACHC. Bank of America lowered their price target on Acadia Healthcare from $105.00 to $90.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. TheStreet upgraded Acadia Healthcare from a “c” rating to a “b-” rating in a research report on Monday, March 4th. Mizuho lowered their price target on Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating on the stock in a research report on Friday, May 3rd. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 price target on the stock in a research report on Thursday, April 25th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $94.00 price target on shares of Acadia Healthcare in a research report on Monday, March 4th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, Acadia Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $87.56.

Acadia Healthcare Stock Down 2.1 %

NASDAQ ACHC opened at $65.36 on Wednesday. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 1.27. The stock has a market capitalization of $6.06 billion, a PE ratio of -466.82, a PEG ratio of 1.97 and a beta of 1.31. Acadia Healthcare Company, Inc. has a 1 year low of $64.11 and a 1 year high of $87.77. The business’s 50-day moving average is $73.08 and its 200 day moving average is $77.06.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.80 by $0.04. The company had revenue of $768.10 million for the quarter, compared to analysts’ expectations of $779.20 million. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. Acadia Healthcare’s quarterly revenue was up 9.1% on a year-over-year basis. During the same period last year, the firm earned $0.75 earnings per share. Sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 3.55 earnings per share for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.